CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

Friday, Jan 23, 2026 7:03 am ET1min read
CRMD--

CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

CorMedix: HC Wainwright Maintains Buy Rating, PT Down to $13.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet